News

Established in 1994,Liquent provides software solutions platform for regulatory submissions and product registration management, as well as complementary business process outsourcing capabilities. Parexel International chairman and CEO Josef

Nafcillin, is a sterile semisynthetic penicillin to treat infections caused by penicillinase producing staphylococci, which have shown susceptibility to the drug. The injection may also be used for

The acquisition is expected to expand OPKO’s presence in Latin American countries and complement its businesses in Chile and Mexico. OPKO believes Silcon is a key element for

Actonel will be manufactured by Ajinomoto and distributed by Eisai, while Benet will be manufactured and distributed by Takeda. Both the companies will share the drug marketing approval

The open-label trial is designed to assess CPX-351 (cytarabine:daunorubicin) liposome injection compared to cytarabine and daunorubicin therapy (7+3) as first-line therapy in high risk (secondary) AML patients 60-75

The Japanese approval of the anticoagulant is based on ARISTOTLE, the pivotal Phase 3 trial conducted in 18,201 NVAF patients, which assessed the safety and efficacy of ELIQUIS

The Japanese Ministry of Health, Labor and Welfare has approved Cimzia as a 200mg syringe for subcutaneous (s.c.) injection to treat adult RA patients who failed to respond

In August 2011, the companies decided to suspend the pramlintide/metreleptin investigational combination therapy development. The decision was based on a commercial re-assessment of the program, which had been

The company is seeking approval for the label expansion of Feraheme to include all iron deficiency anemia (IDA) patients who cannot take oral iron. At present, Ferumoxytol is